cliexa® Partners with Institute of Cognitive Science at University of Colorado Boulder!

, , , , , , , , , , ,
cliexa® partners with the University of Colorado Boulder’s Cognitive and Affective Neuroscience Lab (CANLab) for Multidimensional Pain Tracking and Predictive Analytics Research.
cliexa® Partners with Institute of Cognitive Science at University of Colorado Boulder

Denver, CO, February 28, 2018 — cliexa, Inc., which offers a suite of mobile platforms for chronic disease management, announces its collaboration with CU Boulder’s CANLab and Institute of Cognitive Science (ICS). cliexa will collaborate with CANLab’s team, headed by Tor Wager, a professor of psychology and neuroscience, as they lead in multidimensional pain tracking and predictive analytics research.

CU Boulder jointly filed a provisional patent with cliexa for the multidimensional objective pain concept with CANLab. CANLab focuses on identifying a particular pattern of brain activity, which is diagnostic of physical pain. cliexa-Ease’s mobile platform hosts the research concept and is being used to further develop CANLab’s existing pain studies. cliexa-Ease will deliver an exclusive pain assessment model which, in collaboration with CU Boulder, anticipates commercialization by mid 2018.

Mehmet Kazgan, founder and CEO of cliexa, explains how they are excited about the partnership with Wager’s CANLab because of its “leading research studies for multidimensional pain tracking.” “Working with neuroscientists at CU Boulder is taking the cliexa platform to the next level of objectifying patient outputs with multiple reference points.”

Wager highlights how the collaboration will “expand our ability to understand how emotion affects pain in daily life.” Pavel Goldstein, the scientific lead of the project, adds that the partnership will provide both “an incredible opportunity to establish a platform for researching chronic pain conditions” and “important feedback to pain patients and their clinicians with unique information about patient health.”

About The Cognitive and Affective Neuroscience Lab

Professor Tor Wager leads CANLab, which is housed in CU Boulder’s Institute of Cognitive Science (ICS) and the Psychology and Neuroscience Department. CANLab uses machine-learning to develop fMRI-based biomarkers for clinically relevant outcomes, such as pain. It subsequently tests how psychological factors influence these biomarkers. The lab also engages in collaborative, translational research, which incorporates brain systems-level analyses into the study of clinical disorders, including PTSD, depression, schizophrenia, and chronic pain.

Learn more about CAN Lab at https://canlabweb.colorado.edu

About cliexa
The mobile platform technology developed by cliexa enables patients to track their chronic disease activity by quantifying symptoms using scientifically-proven and clinically-validated scoring models. cliexa delivers quantified disease activity and medication adherence through patient reported outcomes through real-time integration to electronic medical records, which streamline processes and increase efficiency in population health management.

Learn more about cliexa at https://www.cliexa.com

See the Press release here:

/by

cliexa is featured at Colorado Business Roundtable Radio Interview

, , , , , , , , , ,
Tablet Avatar

cliexa has been LIVE at 4:00 on Denver’s Money Talk 1690, or livestream at cobrt.com/live

/by

cliexa® Partners with Preventative Technology Solutions on Risk Assessment Solutions

, , , , , , , , , , , , ,

Denver, CO, December 19, 2017 — cliexa, Inc., developer of a mobile platform for chronic disease management, announces today a collaboration with Preventative Technology Solutions, Inc., (PTSI), provider of medical assessment applications and mHealth prevention services for adolescents and young adults. cliexa has licensed PTSI assessment technology to launch cliexa-Options, a suite of behavioral health apps for primary care and family medicine physicians which will help determine risk level for sexual activity, substance use and other issues. UC Health Longmont is piloting the sexual risk assessment app in its clinic and the service is reimbursable by major insurance providers.

Half of the nearly 20 million new sexually transmitted diseases (STDs) reported each year were among young people between the ages of 15 to 24 and nearly 230,000 babies were born to teen girls aged 15–19 years in 2015, according to the CDC. Undiagnosed STDs cause infertility in 20,000 women annually. Facilitating conversations between patients and their physicians is a significant step necessary to reduce costs and chronic conditions often associated with adolescent behavioral health.

cliexa-Options delivers precise, evidence-based assessments that patients complete on a tablet in the physician’s office before their appointment, creating a structured report using proprietary algorithms for each risk area. The reproductive health app supports early identification of patients at highest risk of acquiring an STD or experiencing an unplanned pregnancy. The mental health and substance use apps identify mental health screening, substance use and resiliency in patients.

cliexa is adding cliexa-Options to its award-winning, digital health platform specializing in patient-reported outcomes and value-based care. The company has partnered with Kaiser Permanente Colorado Rheumatology Clinic at Rock Creek and Colorado Permanente Medical Group since 2016, piloting cliexa-RA for rheumatoid arthritis disease management.

“We are excited to partner with PTSI in providing solutions for adolescent behavioral health,” said Mehmet Kazgan, founder and CEO of cliexa. “Our vision is to build an ecosystem for patients and care teams using the most effective and clinically-validated assessment models and patient-reported outcomes. Combining PTSI’s expertise with cliexa’s digital platform creates state-of-the art products in this space.”

“This is an exciting collaboration, and we anticipate being able to serve our medical providers with better digital health technology services in underutilized areas of primary care,” said Scott Fowle, CEO of Preventative Technology Solutions.

About PTSI
Founded in 2015, PTSI provides health promotion software on a service basis for providers who work with adolescents and emerging adults. The apps improve assessment and treatment outcomes for sexual heath, mental health and substance abuse risks, allowing patients to collaborate with providers to establish healthy behaviors. PTSI technology supports access to population data to analyze, and further understand and improve treatment outcomes. Learn more about PTSI at //www.mypreventtech.com.

About cliexa
The mobile platform technology developed by cliexa enable patients to track their chronic disease activity by quantifying symptoms using scientifically-proven and clinically-validated scoring models. cliexa delivers quantified disease activity and medication adherence through patient reported outcomes by real-time integration to electronic medical records which streamlines processes and increases efficiency in population health management.

Learn more about cliexa at //www.cliexa.com

Press Release:

//www.pr.com/press-release/739441

/by

cliexa has been selected to present at Colorado Capital Conference

, , , , , , ,

The 29th Colorado Capital Conference occurred in November 2017. This conference focused around Micro VCs, the gap that they are filling, and how Angel Investors and Entrepreneurs can best work with them.

MicroVCs play a huge role in the startup ecosystem, but the landscape is changing quickly. This year’s Colorado Capital Conference focuses on the evolving role of Micro VCs which are broadly defined as venture capital funds under $100 million in assets under management. There are new entrants into the MicroVC arena including accelerators and angel funds, and how startups should think about the pros and cons of going with a MicroVC as opposed to one of the larger VCs who can take them all the way to unicorn status.

Rockies Venture Club has identified and selected 8 startups this year and cliexa has been selected as one of the companies to present. With over 200 participants this year, cliexa has pitched to MicroVC’s and angel investors and answered questions.

Here is the link of the companies including cliexa and their short bios:

//www.coloradocapitalconference.org/companies/

 

/by

“STDs are a persistent enemy….”

, , , , , , , , ,
STDs are a persistent enemy
STDs are a persistent enemy

…Jonathan Mermin, director of the CDC’s National Center for STDs and TB Prevention, said in a news release last month. He added that the epidemic is, “…growing in number, and outpacing our ability to respond.” Over 50% of new cases of STDs occur in young people ages 15 – 24, Chlamydia cases the most prominent. Front-line defense–primary care clinics and overloaded physicians. They may feel they do not get honest answers or they don’t have time to ask difficult questions. Young people are not comfortable with face-to-face discussions about reproductive health.

Some physicians don’t know how to broach this sensitive conversation, “This is an awkward topic, especially for men and they avoid having these conversations. cliexa-OPTIONS gives male physicians and clinicians a tool to get through the awkwardness …This epidemic impacts females more because they are left holding the bag.”   So is it a lost cause? No, digital health offers promising solutions.

Why is Primary Care so Important?

Leveraging long-standing relationships with pediatricians and family physicians–an underutilized strategy on the front lines of this devastating battle, helps youth stay healthy. Young people respond to authentic conversations with people they know and trust.  Primary care screenings identify most new cases of Chlamydia. That’s where the cliexa-OPTIONS App, an innovative digital health technology,  plays a crucial role.

cliexa-OPTIONS reduces the cognitive load for clinicians by creating a structured report using our unique scoring algorithm. Our measures are more sensitive to cultural trends young people experience. Three levels of high risk allow tailored, pinpointed conversations that count. Our recent clinical pilot confirmed the benefits of the OPTIONS App.

Risk assessment quality was average before piloting the cliexa-OPTIONS App. After implementing cliexa-OPTIONS, physicians rated the quality of their sexual risk assessment as excellent. The cliexa-OPTIONS App improves reproductive health counseling by “making it easier for my patients to discuss what is REALLY going on with them.” Physicians said the App saves them time and all participants reported that cliexa-OPTIONS supports early identification of youth at highest risk of acquiring an STD.

Positive ROI increases revenue improves quality, tracks efforts, and supports better outcomes for young people. What’s not to love about the cliexa-OPTIONS App?? To find out how to get started, contact the cliexa team.

/by